These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections. Linden P, Williams P, Chan KM. Clin Transplant; 2000 Aug; 14(4 Pt 1):329-39. PubMed ID: 10945204 [Abstract] [Full Text] [Related]
9. In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalis. Warn PA, Morrissey J, Moore CB, Denning DW. Antimicrob Agents Chemother; 2000 Oct; 44(10):2664-71. PubMed ID: 10991841 [Abstract] [Full Text] [Related]
10. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Walsh TJ, Hiemenz JW, Seibel NL, Perfect JR, Horwith G, Lee L, Silber JL, DiNubile MJ, Reboli A, Bow E, Lister J, Anaissie EJ. Clin Infect Dis; 1998 Jun; 26(6):1383-96. PubMed ID: 9636868 [Abstract] [Full Text] [Related]
13. Treatment of Candida infections with amphotericin B lipid complex. Ito JI, Hooshmand-Rad R. Clin Infect Dis; 2005 May 01; 40 Suppl 6():S384-91. PubMed ID: 15809924 [Abstract] [Full Text] [Related]
15. Ultra-long amphotericin B therapy for hepatosplenic candidiasis complicating acute promyelocytic leukaemia. Lai ST, Yeung YM. Clin Lab Haematol; 1996 Mar 01; 18(1):62-3. PubMed ID: 9118611 [No Abstract] [Full Text] [Related]
16. Amphotericin B lipid complex at 3 mg/kg/day for treatment of invasive fungal infections in adults with haematological malignancies. Martino R, Subirá M, Sureda A, Sierra J. J Antimicrob Chemother; 1999 Oct 01; 44(4):569-72. PubMed ID: 10588324 [Abstract] [Full Text] [Related]
17. Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications. Anttila VJ, Elonen E, Nordling S, Sivonen A, Ruutu T, Ruutu P. Clin Infect Dis; 1997 Mar 01; 24(3):375-80. PubMed ID: 9114188 [Abstract] [Full Text] [Related]
18. Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patients. Herbrecht R, Auvrignon A, Andrès E, Guillemain R, Suc A, Eyer D, Pailler C, Letscher-Bru V, Leverger G, Schaison G. Eur J Clin Microbiol Infect Dis; 2001 Feb 01; 20(2):77-82. PubMed ID: 11305476 [Abstract] [Full Text] [Related]
19. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial. Subirà M, Martino R, Gómez L, Martí JM, Estany C, Sierra J. Eur J Haematol; 2004 May 01; 72(5):342-7. PubMed ID: 15059069 [Abstract] [Full Text] [Related]
20. Successful outcome of treatment of a disseminated infection due to Fusarium dimerum in a leukemia patient. Letscher-Bru V, Campos F, Waller J, Randriamahazaka R, Candolfi E, Herbrecht R. J Clin Microbiol; 2002 Mar 01; 40(3):1100-2. PubMed ID: 11880452 [Abstract] [Full Text] [Related] Page: [Next] [New Search]